Page 129 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

108 PART I The Biology and Pathogenesis of Cancer

13. Middleton DJ: Duodenal ulceration associated with gastrin- 36. Bolliger AP, Graham PA, Richard V, et al.: Detection of parathy-
secreting pancreatic tumor in a cat, J Am Vet Med Assoc 183: roid hormone-related protein in cats with humoral hypercalcemia
461–462, 1983. of malignancy, Vet Clin Pathol 31:3–8, 2002.
VetBooks.ir 14. Elliott J, Dobson JM, Dunn JK, et al.: Hypercalce- 37. Schenck PA, Chew DJ, Nagoda LA, et al.: Disorders of calcium:
hypercalcemia and hypocalcemia. In DiBartola SP, editor: Fluid,
mia in the dog: a study of 40 cases, J Small Anim Pract 32:
564–567, 1991.
15. Messinger JS, Windham WR, Ward CR: Ionized hypercalcemia in electrolyte, and acid-base disorders in small animal practice, ed 4, St.
Louis, 2012, Elsevier, pp 20–194.
dogs: a retrospective study of 109 cases (1998–2003), J Vet Intern 38. Epstein FH: The physiology of parathyroid hormone-related pro-
Med 23:514–519, 2009. tein, N Engl J Med 342:177–186, 2000.
16. Savary KC, Price GS, Vaden SL: Hypercalcemia in cats: a retro- 39. Grӧne A, Werkmeister JR, Steinmayer CL, et al.: Parathyroid
spective study of 71 cases (1991–1997), J Vet Intern Med 14: hormone-related protein in normal and neoplastic canine tissues:
184–189, 2000. immunohistochemical localization and biochemical extraction, Vet
17. Lucas P, Lacoste H, deLorimier L-P, et al.: Treating paraneoplastic Pathol 31:308–315, 1994.
hypercalcemia in dogs and cats, Vet Med 314–330, 2007. 40. Rosol TJ, Capen CC: Mechanisms of cancer-induced hypercalce-
18. Vasilopulos RJ, Mackin A: Humoral hypercalcemia of malignancy: mia, Lab Invest 67:680–702, 1992.
pathophysiology and clinical signs, Compend Cont Educ Sm Anim 41. Rosol TJ, Nagode LA, Couto CG, et al.: Parathyroid hormone
Pract 25:122–128, 2003. (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D
19. Rebhun RB, Kent MS, Vorrofka SAEB, et al.: CHOP chemother- in dogs with cancer-associated hypercalcemia, Endocrinology
apy for the treatment of canine multicentric T-cell lymphoma, Vet 131:1157–1164, 1992.
Comp Oncol 9:38–44, 2010. 42. Schenck PA, Chew DJ: Prediction of serum ionized calcium con-
20. Brodsky EM, Mauldin GN, Lachowicz JL, et al.: Asparaginase centration by use of serum total calcium concentration in dogs, Am
and MOPP treatment of dogs with lymphoma, J Vet Intern Med J Vet Res 66:1330–1336, 2005.
23:578–584, 2009. 43. Vasilopulos RJ, Mackin A: Humoral hypercalcemia of malignancy:
21. Williams LE, Gliatto JM, Dodge RK, et al.: Carcinoma of the apo- diagnosis and treatment, Compend Cont Ed Sm Anim Pract 25:129–
crine glands of the anal sac in dogs: 113 cases (1985–1995), J Am 137, 2003.
Vet Med Assoc 223:825–831, 2003. 44. Milner RJ, Farese J, Henry CJ, et al.: Bisphosphonates in cancer,
22. Ross JT, Scavelli TD, Matthieson DT, et al.: Adenocarcinoma of J Vet Intern Med 18:597–604, 2004.
the apocrine glands of the anal sac in dogs: a review of 32 cases, 45. Hostutler RA, Chew DJ, Jaeger JQ, et al.: Uses and effectiveness of
J Am Anim Hosp Assoc 27:349–355, 1991. pamidronate disodium for treatment of dogs and cats with hyper-
23. Pressler BM, Rotstein DS, Law JM, et al.: Hypercalcemia and calcemia, J Vet Intern Med 19:29–33, 2005.
high parathyroid hormone-related protein concentration associ- 46. Major P, Lortholary A, Hon J, et al.: Zoledronic acid is superior
ated with malignant melanoma in a dog, J Am Vet Med Assoc 221: to pamidronate in the treatment of hypercalemia of malignancy: a
263–265, 2002. pooled analysis of two randomized, controlled clinical trials, J Clin
24. Kleiter M, Hirt R, Kirtz G, et al.: Hypercalcaemia associated with Oncol 19:558–567, 2001.
chronic lymphocytic leukaemia in a Giant Schnauzer, Aust Vet J 47. Fan TM, deLorimier LP, Garrett LD, et al.: The bone biologic
79:335–338, 2001. effects of zoledronate in healthy dogs and dogs with malignant
25. Furtado AR, Parrinello L, Merlo M, et al.: Primary penile adeno- osteolysis, J Vet Intern Med 22:380–387, 2008.
carcinoma with concurrent hypercalcemia of malignancy in a dog, 48. Price GS, Page RL, Fischer B, et al.: Efficacy and toxicity of doxo-
J Small Anim Pract 56:289–292, 2015. rubicin/ cyclophosphamide maintenance therapy in dogs with mul-
26. Robat CS, Cesario L, Gaeta R, et al.: Clinical features, treatment ticentric lymphosarcoma, J Vet Intern Med 5:259–262, 1991.
options, and outcome in dogs with thymoma: 116 cases (1999– 49. Goutal CM, Brugmann BL, Ryan KA: Insulinoma in dogs: a
2010), J Am Vet Med Assoc 243:1448–1454, 2013. review, J Am Anim Hosp Assoc 48:151–163, 2012.
27. Merrick CH, Schleis SE, Smith AN, et al.: Hypercalemia of malig- 50. Tobin RL, Nelson RW, Lucroy MD, et al.: Outcome of surgical
nancy associated with renal cell carcinoma in a dog, J Am Anim versus medical treatment of dogs with beta cell neoplasia: 39 cases
Hosp Assoc 49:385–388, 2013. (1990-1997), J Am Vet Med Assoc 215:226–230, 1999.
28. Gajanayake I, Priestnall SL, Benigni L, et al.: Paraneoplastic hyper- 51. Buishand FO, van Erp MG, Groenveld HA, et al.: Expression of
calcemia in a dog with benign renal angiomyxoma, J Vet Diagn insulin-like growth factor-1 by canine insulinomas and their metas-
Invest 22:775–780, 2010. tases, Vet J 191:334–340, 2012.
29. Neihaus SA, Winter JE, Goring RL, et al.: Primary clitoral adeno- 52. Finotello R, Ressel L, Arvigo M, et al.: Canine pancreatic islet cell
carcinoma with secondary hypercalcemia of malignancy in a dog, tumours secreting insulin-like growth factor type 2: a rare entity,
J Am Anim Hosp Assoc 46:193–196, 2010. Vet Comp Oncol 14:170–180, 2016.
30. Henry CJ, Lanevschi A, Marks SL, et al.: Acute lymphoblastic leu- 53. Leifer CE, Peterson ME, Matus RE, et al.: Hypoglycemia associated
kemia, hypercalcemia, and pseudohyperkalemia in a dog, J Am Vet with nonislet cell tumor in 13 dogs, J Am Vet Med Assoc 186:53–55,
Med Assoc 208:237–239, 1996. 1985.
31. Dhaliwal RS, Tank KN: Parathyroid hormone-related peptide and 54. Zini E, Glaus TM, Minuto F, et al.: Paraneoplastic hypoglycemia
hypercalcemia in a dog with functional keratinizing ameloblas- due to an insulin-like growth factor type-II secreting hepatocellular
toma, Vet Comp Oncol 3:90–100, 2005. carcinoma in a dog, J Vet Intern Med 21:193–195, 2007.
32. Anderson GM, Lane I, Fischer J, et al.: Hypercalcemia and para- 55. Beaudry D, Knapp DW, Montgomery T, et al.: Smooth muscle
thyroid hormone-related protein in a dog with undifferentiated tumors associated with hypoglycemia in four dogs. Clinical presen-
nasal carcinoma, Can Vet J 40, 1999. 341–341. tation, treatment, and tumor immunohistochemical staining, J Vet
33. Klausner JS, Bell FW, Hayden DW, et al.: Hypercalcemia in two Intern Med 9:415–418, 1995.
cats with squamous cell carcinoma, J Am Vet Med Assoc 196:103– 56. Bagley RS, Levy JK, Malarkey DE: Hypoglycemia associated with
105, 1990. intra-abdominal leiomyoma and leiomyosarcoma in six dogs, J Am
34. Sheafor SE, Gamblin RM, Couto CG: Hypercalcemia in Vet Med Assoc 208:69–71, 1996.
two cats with multiple myeloma, J Am Anim Hosp Assoc 32: 57. Cohen M, Post GS, Wright JC: Gastrointestinal leiomyosarcoma in
503–508, 1996. 14 dogs, J Vet Intern Med 17:107–110, 2003.
35. Anderson TE, Legendre AM, McEntee MM: Probable hypercal- 58. Rossi G, Errico G, Perez P, et al.: Paraneoplastic hypoglycemia in a
cemia of malignancy in a cat with bronchogenic adenocarcinoma, diabetic dog with an insulin growth factor-2-producing mammary
J Am Anim Hosp Assoc 36:52–55, 2000. carcinoma, Vet Clin Pathol 39:480–484, 2010.